These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35403686)

  • 1. Decline in attention-deficit hyperactivity disorder traits over the life course in the general population: trajectories across five population birth cohorts spanning ages 3 to 45 years.
    Wootton RE; Riglin L; Blakey R; Agnew-Blais J; Caye A; Cadman T; Havdahl A; Gonçalves H; Menezes AMB; Wehrmeister FC; Rimfeld K; Davey Smith G; Eley TC; Rohde LA; Arseneault L; Moffitt TE; Stergiakouli E; Thapar A; Tilling K
    Int J Epidemiol; 2022 Jun; 51(3):919-930. PubMed ID: 35403686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shared genetic influences between dimensional ASD and ADHD symptoms during child and adolescent development.
    Stergiakouli E; Davey Smith G; Martin J; Skuse DH; Viechtbauer W; Ring SM; Ronald A; Evans DE; Fisher SE; Thapar A; St Pourcain B
    Mol Autism; 2017; 8():18. PubMed ID: 28392908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-development of attention deficit hyperactivity disorder and autistic trait trajectories from childhood to early adulthood.
    Shakeshaft A; Heron J; Blakey R; Riglin L; Davey Smith G; Stergiakouli E; Tilling K; Thapar A
    J Child Psychol Psychiatry; 2023 Nov; 64(11):1596-1607. PubMed ID: 37350028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are fetal growth impairment and preterm birth causally related to child attention problems and ADHD? Evidence from a comparison between high-income and middle-income cohorts.
    Murray E; Pearson R; Fernandes M; Santos IS; Barros FC; Victora CG; Stein A; Matijasevich A
    J Epidemiol Community Health; 2016 Jul; 70(7):704-9. PubMed ID: 26767410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Links between co-occurring social-communication and hyperactive-inattentive trait trajectories.
    St Pourcain B; Mandy WP; Heron J; Golding J; Davey Smith G; Skuse DH
    J Am Acad Child Adolesc Psychiatry; 2011 Sep; 50(9):892-902.e5. PubMed ID: 21871371
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Akutagava-Martins GC; Salatino-Oliveira A; Kieling C; Genro JP; Polanczyk GV; Anselmi L; Menezes AM; Gonçalves H; Wehrmeister FC; Barros FC; Callegari-Jacques SM; Rohde LA; Hutz MH
    J Psychiatry Neurosci; 2016 Oct; 41(6):405-412. PubMed ID: 27327562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Genetic Risk Variants With Attention-Deficit/Hyperactivity Disorder Trajectories in the General Population.
    Riglin L; Collishaw S; Thapar AK; Dalsgaard S; Langley K; Smith GD; Stergiakouli E; Maughan B; O'Donovan MC; Thapar A
    JAMA Psychiatry; 2016 Dec; 73(12):1285-1292. PubMed ID: 27806167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
    Storebø OJ; Ramstad E; Krogh HB; Nilausen TD; Skoog M; Holmskov M; Rosendal S; Groth C; Magnusson FL; Moreira-Maia CR; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Forsbøl B; Simonsen E; Gluud C
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009885. PubMed ID: 26599576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention-Deficit/Hyperactivity Disorder Trajectories From Childhood to Young Adulthood: Evidence From a Birth Cohort Supporting a Late-Onset Syndrome.
    Caye A; Rocha TB; Anselmi L; Murray J; Menezes AM; Barros FC; Gonçalves H; Wehrmeister F; Jensen CM; Steinhausen HC; Swanson JM; Kieling C; Rohde LA
    JAMA Psychiatry; 2016 Jul; 73(7):705-12. PubMed ID: 27192050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for the attention deficit hyperactivity disorder phenotype using the strength and difficulties questionnaire.
    Ullebø AK; Posserud MB; Heiervang E; Gillberg C; Obel C
    Eur Child Adolesc Psychiatry; 2011 Sep; 20(9):451-8. PubMed ID: 21833627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between preterm infant size at 1 year and ADHD later in life: data from 1993 and 2004 Pelotas Birth Cohorts.
    Soldateli B; Silveira RC; Procianoy RS; Belfort M; Caye A; Leffa D; Franz AP; Barros FC; Santos IS; Matijasevich A; Barros AJD; Tovo-Rodrigues L; Menezes AMB; Gonçalves H; Wehrmeister FC; Rohde LAP
    Eur Child Adolesc Psychiatry; 2023 Sep; 32(9):1589-1597. PubMed ID: 35274169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic risk for attention-deficit/hyperactivity disorder contributes to neurodevelopmental traits in the general population.
    Martin J; Hamshere ML; Stergiakouli E; O'Donovan MC; Thapar A
    Biol Psychiatry; 2014 Oct; 76(8):664-71. PubMed ID: 24673882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating attention-deficit hyperactivity disorder and autism spectrum disorder traits in the general population: What happens in adult life?
    Riglin L; Leppert B; Langley K; Thapar AK; O'Donovan MC; Davey Smith G; Stergiakouli E; Tilling K; Thapar A
    J Child Psychol Psychiatry; 2021 Apr; 62(4):449-457. PubMed ID: 32663329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the validity of the Strengths and Difficulties Questionnaire to assess ADHD in young adulthood.
    Riglin L; Agha SS; Eyre O; Bevan Jones R; Wootton RE; Thapar AK; Collishaw S; Stergiakouli E; Langley K; Thapar A
    Psychiatry Res; 2021 Jul; 301():113984. PubMed ID: 33991992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Attention-Deficit/Hyperactivity Disorder Diagnosis With Adolescent Quality of Life.
    Kazda L; McGeechan K; Bell K; Thomas R; Barratt A
    JAMA Netw Open; 2022 Oct; 5(10):e2236364. PubMed ID: 36227598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention-deficit/hyperactivity disorder polygenic risk scores predict attention problems in a population-based sample of children.
    Groen-Blokhuis MM; Middeldorp CM; Kan KJ; Abdellaoui A; van Beijsterveldt CE; Ehli EA; Davies GE; Scheet PA; Xiao X; Hudziak JJ; Hottenga JJ; ; Neale BM; Boomsma DI
    J Am Acad Child Adolesc Psychiatry; 2014 Oct; 53(10):1123-9.e6. PubMed ID: 25245356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predictive validity of the Strengths and Difficulties Questionnaire for child attention-deficit/hyperactivity disorder.
    Overgaard KR; Madsen KB; Oerbeck B; Friis S; Obel C
    Eur Child Adolesc Psychiatry; 2019 May; 28(5):625-633. PubMed ID: 30220077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental trajectories of DSM-IV symptoms of attention-deficit/hyperactivity disorder: genetic effects, family risk and associated psychopathology.
    Larsson H; Dilshad R; Lichtenstein P; Barker ED
    J Child Psychol Psychiatry; 2011 Sep; 52(9):954-63. PubMed ID: 21434915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and Environmental Influences on the Developmental Course of Attention-Deficit/Hyperactivity Disorder Symptoms From Childhood to Adolescence.
    Pingault JB; Viding E; Galéra C; Greven CU; Zheng Y; Plomin R; Rijsdijk F
    JAMA Psychiatry; 2015 Jul; 72(7):651-8. PubMed ID: 25945901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.